Evaluation of whole-brain oxygen metabolism in Alzheimer's disease using QSM and quantitative BOLD

CMRO₂ mapping with the QQ-CCTV method - which is readily available in MR systems for clinical practice - can be a potential biomarker for AD. In addition, CMRO₂ in the hippocampus may be a useful tool for monitoring cognitive impairment.